Dynacure   Report issue

For profit Phase 2
Founded: Illkirch France (2016)

Organization Overview

First Clinical Trial
2019
NCT04033159
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dynacure | Dynacure SAS

Active Ingredients

Drugs in Phase 2 Trials (1)

dyn101 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Muscular Diseases (Phase 2)

Myopathies, Structural, Congenital (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1